See more : Divio Technologies AB (publ) (DIVIO-B.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Lifeline Biotechnologies, Inc. (LLBO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lifeline Biotechnologies, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Abacus Mining & Exploration Corporation (0UFP.L) Income Statement Analysis – Financial Results
- Fujian Sanmu Group Co., Ltd. (000632.SZ) Income Statement Analysis – Financial Results
- Lindbergh S.p.A. (LDB.MI) Income Statement Analysis – Financial Results
- Mason Group Holdings Limited (0273.HK) Income Statement Analysis – Financial Results
- Daesang Holdings Co., Ltd. (084690.KS) Income Statement Analysis – Financial Results
Lifeline Biotechnologies, Inc. (LLBO)
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 350.00K | 60.01K | 65.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 630.00 | 2.52K | 2.52K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 349.37K | 57.49K | 62.48K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 99.82% | 95.80% | 96.12% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 43.39K | 107.46K | 51.55K | 59.87K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 43.39K | 107.46K | 51.55K | 59.87K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 43.39K | 108.09K | 54.07K | 62.39K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 630.00 | 2.52K | 2.52K |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -43.39K | 242.54K | 8.46K | 5.13K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 69.30% | 14.10% | 7.89% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -43.39K | 241.91K | 5.94K | 2.61K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 69.12% | 9.90% | 4.02% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 | -3.00 | 5.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -43.39K | 241.92K | 5.94K | 2.62K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 69.12% | 9.89% | 4.02% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | -161.14K | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -43.39K | 241.92K | 5.94K | 2.62K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 69.12% | 9.89% | 4.02% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 3.14B | 3.14B | 3.14B | 3.12B |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 3.14B | 3.14B | 3.14B | 3.12B |
Source: https://incomestatements.info
Category: Stock Reports